a stepDeciding whether to go

The step before any money moves: a person weighs a price, a queue or a refusal at home against a procedure in another country. Nobody is a patient yet and no contract exists, so the exposure here is informational — what is written down, who wrote it, and who is paid when it is believed.

The published reasons people give divide three ways: a bill at home they cannot meet, a wait at home measured in months, and a treatment at home that is unlawful, unfunded or unavailable to them. The three carry different pressure. A person in a queue can wait longer; a person refused cannot.

What gets read at this stage is mostly commercial. Penney and colleagues took 17 English-language Canadian broker websites in the summer of 2010 and counted what they told a reader: 47% made no mention of risks at all, only two of the seventeen raised risks specific to travelling for care, 17.6% addressed possible negative outcomes, 70.6% carried patient testimonials, and 29.4% named a price. Their conclusion was that Canadian brokers "currently lack a common standard of care and accreditation, and are widely lacking in providing adequate risk communication".

The medical side of the decision has its own timetable, and it sits later than most people expect. The CDC Yellow Book puts the pre-travel consultation "4–6 weeks before travel", which is usually after the destination has been chosen and often after a deposit has been paid. Inference — by the time a clinician who knows about travel medicine is in the conversation, most of the decisions this site describes have already been made.

No register anywhere this project could read records who decides to travel, or why. The counts that circulate — patients per year, percentage cheaper — come from market summaries that resell each other and generally count foreign nationals treated at a hospital, which includes every resident expatriate with a chest infection. A hospital's own count of its own international patients, a national statistics office, or a peer-reviewed study is a narrower number and says what it counts.

The questions that have documentary answers at this stage are dull and specific: which named surgeon will operate, what the price covers and excludes in the provider's own words, who provides follow-up and where, and which country's law governs the contract being signed. Each of those has a paper answer or it does not exist.

As of 16 September 2026 the evidence a person meets while deciding is written almost entirely by parties paid when the answer is yes. The counterweight published by states — the CDC Yellow Book chapter, the NHS page on cosmetic surgery abroad — describes hazards rather than providers, and names no hospital.